comparemela.com

Page 25 - Ed Susman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mixed Results With Pemafibrate in Patients With Type 2 Diabetes

No impact on CV events in PROMINENT; developer brings trial to an end

United statesFort pierceBaylor college of medicineAruna das pradhanEd susmanSalim viraniDas pradhanAmerican heart associationBrigham women hospital harvard medical schoolHarvard medical schoolNew england journalBaylor collegeEngland journalEnglj med

Anti-Inflammatory Agents May Have Role in COVID-19 Pneumonia

Infliximab and abatacept showed trends for improved outcomes in ACTIV-1 IM trial

North carolinaUnited statesFort pierceEmily koEd susmanAdarsh bhimrajDuke university health system in durhamDuke university health systemHouston methodist

Fluticasone Delivery System Reduced Exacerbations of Chronic Rhinosinusitis

Results from two randomized trials show the device also reduced need for antibiotics

United statesFort pierceEd susmanZachary solerRamy mahmoudUniversity of south carolinaMedical universitySouth carolinaMedpage today

Sabizabulin Benefit in Hospitalized COVID Seen Early in Disease Course

Fewer deaths with microtubule disruptor for patients only needing oxygen via mask or nasal prongs

United statesFort pierceEd susmanAdarsh bhimrajPaula skardaWorld health organizationRegions hospitalHouston methodist hospital

Ivermectin: Still on a Losing Streak as COVID-19 Treatment

ACTIV-6 trial shows no time-to-recovery benefit with anti-parasitic in mild-to-moderate disease

New yorkUnited statesFort pierceEd susmanAdarsh bhimrajMatthew mccarthyWeill cornell medicineNew york city

vimarsana © 2020. All Rights Reserved.